Answers are grounded in this paper and cite their sources.
The autologous cellular therapy exagamglogene autotemcel is generated by editing an erythroid-specific enhancer of BCL11A . Could another site be edited unintentionally? This study gauged the likelihood of off-target editing.
No takes yet. Share an insight, caveat, or question.
Zappala et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: